Free tool
Cell therapy stocks
We cover 1 company grouped under the Cell therapy theme. The median market value in the group is $30.03M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −38.9% to −38.9% across the middle 80 percent of the group, with a median of −38.9%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
1 company of 86 matches these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| SVA.TO | Sernova Biotherapeutics Inc | $30.03M | Micro cap | −38.89% | Sep 10, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.